|
1.
|
Lanzara,
R. Preventing Rapid Receptor Desensitization
at the beta-1-Adrenergic Receptor with
Agonist/Antagonist Combinations The Chemweb Preprint
Server, http://preprint.chemweb.com/medichem/0302002
(2003). html
or pdf
|
|
2.
|
Rubenstein,
L. and Lanzara, R. Activation of G Protein-Coupled
Receptors Entails Cysteine Modulation of
Agonist Binding, J. Molecular Structure (Theochem)
430/1-3: 57-71 (1998). pdf
|
|
3.
|
|
|
4.
|
Lanzara:
A Method for determining drug compositions
to prevent desensitization of cellular receptors.
U.S. Pat. 5,597,699 (1997).pdf
|
|
5.
|
Lanzara:
Compositions to enhance the efficacy and
safety of bio-pharmaceutical drugs. U.S.
Pat. 6,593,094 (2003).pdf
|
|
6.
|
Lanzara,
R. Desensitization
of a balance with Langmuir binding of weights.
arXiv 2003, http://arXiv.org/abs/physics/0303055.html or pdf
|
|
7.
|
|
|
8.
|
APPENDIX
SECTION - Derivation
of the Method in MS Word, or html( 2004).
|
|
9.
|
APPENDIX2
- Diagram of
Receptor Activation MS
Word, or html(
2004).
|
|
10.
|
|
|
11.
|
Essay
- Better drugs without genetic testing?
html or MS Word( 2004
new).
|
|
12.
|
Essay
- The role of drug-receptor desensitization
(tolerance, fade, tachyphylaxis or down-regulation)
for future drug development html
or MS
Word ( 2004 new).
|
|
13.
|
|
|
|
|
